Naseem Zojwalla - 11 Dec 2023 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 11 Dec 2023
Net transactions value: +$20,358
Form type: 4
Filing time: 12 Dec 2023, 17:55:11 UTC
Previous filing: 07 Dec 2023
Next filing: 29 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$20,358	+2,900	+6.6%	$7.02	46,664	11 Dec 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-2,900	-1.2%	$0.000000	234,000	11 Dec 2023	Common Stock	2,900	$7.02	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.